ID   GNMT_RAT                Reviewed;         293 AA.
AC   P13255;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   29-MAY-2024, entry version 180.
DE   RecName: Full=Glycine N-methyltransferase;
DE            EC=2.1.1.20 {ECO:0000269|PubMed:12859184, ECO:0000269|PubMed:3838667};
DE   AltName: Full=Folate-binding protein {ECO:0000303|PubMed:6587377};
GN   Name=Gnmt; Synonyms=Fbp-cII {ECO:0000303|PubMed:6587377};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], PROTEIN SEQUENCE OF 2-7, CLEAVAGE
RP   OF INITIATOR METHIONINE, AND ACETYLATION AT VAL-2.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=2822402; DOI=10.1111/j.1432-1033.1987.tb13398.x;
RA   Ogawa H., Konishi K., Takata Y., Nakashima H., Fujioka M.;
RT   "Rat glycine methyltransferase. Complete amino acid sequence deduced from a
RT   cDNA clone and characterization of the genomic DNA.";
RL   Eur. J. Biochem. 168:141-151(1987).
RN   [2]
RP   SUBCELLULAR LOCATION, AND FOLATE BINDING.
RX   PubMed=6587377; DOI=10.1073/pnas.81.12.3631;
RA   Cook R.J., Wagner C.;
RT   "Glycine N-methyltransferase is a folate binding protein of rat liver
RT   cytosol.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:3631-3634(1984).
RN   [3]
RP   CATALYTIC ACTIVITY, FUNCTION, ACTIVITY REGULATION, AND FOLATE BINDING.
RX   PubMed=3838667; DOI=10.1016/s0006-291x(85)80006-1;
RA   Wagner C., Briggs W.T., Cook R.J.;
RT   "Inhibition of glycine N-methyltransferase activity by folate derivatives:
RT   implications for regulation of methyl group metabolism.";
RL   Biochem. Biophys. Res. Commun. 127:746-752(1985).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 2-293 IN COMPLEX WITH
RP   S-ADENOSYL-L-METHIONINE.
RC   TISSUE=Liver;
RX   PubMed=8810903; DOI=10.1021/bi961068n;
RA   Fu Z., Hu Y., Konishi K., Takata Y., Ogawa H., Gomi T., Fujioka M.,
RA   Takusagawa F.;
RT   "Crystal structure of glycine N-methyltransferase from rat liver.";
RL   Biochemistry 35:11985-11993(1996).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=9655336; DOI=10.1002/pro.5560070608;
RA   Pattanayek R., Newcomer M.E., Wagner C.;
RT   "Crystal structure of apo-glycine N-methyltransferase (GNMT).";
RL   Protein Sci. 7:1326-1331(1998).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=10756111; DOI=10.1006/jmbi.2000.3637;
RA   Huang Y., Komoto J., Konishi K., Takata Y., Ogawa H., Gomi T., Fujioka M.,
RA   Takusagawa F.;
RT   "Mechanisms for auto-inhibition and forced product release in glycine N-
RT   methyltransferase: crystal structures of wild-type, mutant R175K and S-
RT   adenosylhomocysteine-bound R175K enzymes.";
RL   J. Mol. Biol. 298:149-162(2000).
RN   [7] {ECO:0007744|PDB:1NBH, ECO:0007744|PDB:1NBI}
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 2-292 IN COMPLEXES WITH
RP   S-ADENOSYL-L-METHIONINE AND ACETATE, MUTAGENESIS OF TYR-34; ARG-176 AND
RP   TYR-221, FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=12859184; DOI=10.1021/bi034245a;
RA   Takata Y., Huang Y., Komoto J., Yamada T., Konishi K., Ogawa H., Gomi T.,
RA   Fujioka M., Takusagawa F.;
RT   "Catalytic mechanism of glycine N-methyltransferase.";
RL   Biochemistry 42:8394-8402(2003).
RN   [8] {ECO:0007744|PDB:2IDJ, ECO:0007744|PDB:2IDK}
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 2-292 IN COMPLEX WITH
RP   5-METHYLTETRAHYDROFOLATE, AND ACTIVITY REGULATION.
RX   PubMed=17158459; DOI=10.1074/jbc.m610384200;
RA   Luka Z., Pakhomova S., Loukachevitch L.V., Egli M., Newcomer M.E.,
RA   Wagner C.;
RT   "5-methyltetrahydrofolate is bound in intersubunit areas of rat liver
RT   folate-binding protein glycine N-methyltransferase.";
RL   J. Biol. Chem. 282:4069-4075(2007).
RN   [9] {ECO:0007744|PDB:3THR, ECO:0007744|PDB:3THS}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-293 IN COMPLEXES WITH
RP   5-METHYLTETRAHYDROFOLATE PENTAGLUTAMATE AND 5-METHYLTETRAHYDROFOLATE
RP   MONOGLUTAMATE, AND SUBUNIT.
RX   PubMed=22037183; DOI=10.1016/j.bbapap.2011.10.008;
RA   Luka Z., Pakhomova S., Loukachevitch L.V., Newcomer M.E., Wagner C.;
RT   "Differences in folate-protein interactions result in differing inhibition
RT   of native rat liver and recombinant glycine N-methyltransferase by 5-
RT   methyltetrahydrofolate.";
RL   Biochim. Biophys. Acta 1824:286-291(2012).
CC   -!- FUNCTION: Catalyzes the methylation of glycine by using S-
CC       adenosylmethionine (AdoMet) to form N-methylglycine (sarcosine) with
CC       the concomitant production of S-adenosylhomocysteine (AdoHcy), a
CC       reaction regulated by the binding of 5-methyltetrahydrofolate. Possible
CC       crucial role in the regulation of tissue concentration of AdoMet and of
CC       metabolism of methionine. {ECO:0000250|UniProtKB:Q14749}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycine + S-adenosyl-L-methionine = H(+) + S-adenosyl-L-
CC         homocysteine + sarcosine; Xref=Rhea:RHEA:19937, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:57433, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789; EC=2.1.1.20;
CC         Evidence={ECO:0000269|PubMed:12859184, ECO:0000269|PubMed:3838667};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19938;
CC         Evidence={ECO:0000305|PubMed:12859184};
CC   -!- ACTIVITY REGULATION: Inhibited by 5-methyltetrahydrofolate
CC       monoglutamate and by 5-methyltetrahydrofolate pentaglutamate,
CC       inhibition is much more effective by the pentaglutamate form than by
CC       the monoglutamate form (PubMed:3838667). Two molecules of 5-
CC       methyltetrahydrofolate are bound per tetramer. The binding sites are
CC       localized between subunits. Inhibitor binding may preclude movements of
CC       the polypeptide chain that are necessary for enzyme activity.
CC       {ECO:0000269|PubMed:17158459, ECO:0000269|PubMed:22037183,
CC       ECO:0000269|PubMed:3838667}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=36 uM for S-adenosyl-L-methionine {ECO:0000269|PubMed:12859184};
CC         KM=0.43 uM for glycine {ECO:0000269|PubMed:12859184};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:17158459,
CC       ECO:0000269|PubMed:22037183}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:6587377}.
CC   -!- TISSUE SPECIFICITY: Abundant in liver.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding methyltransferase
CC       superfamily. Glycine N-methyltransferase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00932}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X06150; CAA29508.1; -; mRNA.
DR   EMBL; X07833; CAA30686.1; -; Genomic_DNA.
DR   PIR; S00112; S00112.
DR   RefSeq; NP_058780.1; NM_017084.1.
DR   PDB; 1BHJ; X-ray; 2.50 A; A/B=2-293.
DR   PDB; 1D2C; X-ray; 2.50 A; A/B=2-293.
DR   PDB; 1D2G; X-ray; 2.50 A; A/B=2-293.
DR   PDB; 1D2H; X-ray; 3.00 A; A/B/C/D=2-293.
DR   PDB; 1KIA; X-ray; 2.80 A; A/B/C/D=2-293.
DR   PDB; 1NBH; X-ray; 2.80 A; A/B/C/D=2-293.
DR   PDB; 1NBI; X-ray; 3.00 A; A/B/C/D=2-293.
DR   PDB; 1XVA; X-ray; 2.20 A; A/B=2-293.
DR   PDB; 2IDJ; X-ray; 2.35 A; A/B/C/D=2-293.
DR   PDB; 2IDK; X-ray; 2.55 A; A/B/C/D=2-293.
DR   PDB; 3THR; X-ray; 2.00 A; A/B/C/D=2-293.
DR   PDB; 3THS; X-ray; 2.50 A; A/B/C/D=2-293.
DR   PDBsum; 1BHJ; -.
DR   PDBsum; 1D2C; -.
DR   PDBsum; 1D2G; -.
DR   PDBsum; 1D2H; -.
DR   PDBsum; 1KIA; -.
DR   PDBsum; 1NBH; -.
DR   PDBsum; 1NBI; -.
DR   PDBsum; 1XVA; -.
DR   PDBsum; 2IDJ; -.
DR   PDBsum; 2IDK; -.
DR   PDBsum; 3THR; -.
DR   PDBsum; 3THS; -.
DR   AlphaFoldDB; P13255; -.
DR   SMR; P13255; -.
DR   STRING; 10116.ENSRNOP00000022307; -.
DR   iPTMnet; P13255; -.
DR   PhosphoSitePlus; P13255; -.
DR   PaxDb; 10116-ENSRNOP00000022307; -.
DR   Ensembl; ENSRNOT00000022307.5; ENSRNOP00000022307.2; ENSRNOG00000016349.5.
DR   Ensembl; ENSRNOT00055014634; ENSRNOP00055011702; ENSRNOG00055008666.
DR   Ensembl; ENSRNOT00060041013; ENSRNOP00060033940; ENSRNOG00060023668.
DR   Ensembl; ENSRNOT00065046482; ENSRNOP00065038109; ENSRNOG00065026940.
DR   GeneID; 25134; -.
DR   KEGG; rno:25134; -.
DR   UCSC; RGD:2719; rat.
DR   AGR; RGD:2719; -.
DR   CTD; 27232; -.
DR   RGD; 2719; Gnmt.
DR   eggNOG; ENOG502QRN6; Eukaryota.
DR   GeneTree; ENSGT00390000006845; -.
DR   HOGENOM; CLU_069129_0_0_1; -.
DR   InParanoid; P13255; -.
DR   OrthoDB; 2902671at2759; -.
DR   PhylomeDB; P13255; -.
DR   TreeFam; TF324814; -.
DR   BRENDA; 2.1.1.20; 5301.
DR   Reactome; R-RNO-389661; Glyoxylate metabolism and glycine degradation.
DR   SABIO-RK; P13255; -.
DR   EvolutionaryTrace; P13255; -.
DR   PRO; PR:P13255; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000016349; Expressed in liver and 8 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0034708; C:methyltransferase complex; IMP:CAFA.
DR   GO; GO:0005542; F:folic acid binding; IDA:UniProtKB.
DR   GO; GO:0016594; F:glycine binding; IDA:UniProtKB.
DR   GO; GO:0017174; F:glycine N-methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:CAFA.
DR   GO; GO:1904047; F:S-adenosyl-L-methionine binding; IMP:CAFA.
DR   GO; GO:0008757; F:S-adenosylmethionine-dependent methyltransferase activity; IDA:RGD.
DR   GO; GO:0098603; F:selenol Se-methyltransferase activity; TAS:Reactome.
DR   GO; GO:0006544; P:glycine metabolic process; IMP:CAFA.
DR   GO; GO:0005977; P:glycogen metabolic process; ISO:RGD.
DR   GO; GO:0006555; P:methionine metabolic process; ISO:RGD.
DR   GO; GO:0032259; P:methylation; IMP:CAFA.
DR   GO; GO:0006730; P:one-carbon metabolic process; ISO:RGD.
DR   GO; GO:0051289; P:protein homotetramerization; IPI:UniProtKB.
DR   GO; GO:0006111; P:regulation of gluconeogenesis; ISO:RGD.
DR   GO; GO:0046498; P:S-adenosylhomocysteine metabolic process; IDA:RGD.
DR   GO; GO:0046500; P:S-adenosylmethionine metabolic process; IDA:UniProtKB.
DR   GO; GO:1901052; P:sarcosine metabolic process; IMP:RGD.
DR   CDD; cd02440; AdoMet_MTases; 1.
DR   DisProt; DP00031; -.
DR   Gene3D; 3.30.46.10; Glycine N-methyltransferase, chain A, domain 1; 1.
DR   Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1.
DR   InterPro; IPR014369; Gly/Sar_N_MeTrfase.
DR   InterPro; IPR041698; Methyltransf_25.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   PANTHER; PTHR16458; GLYCINE N-METHYLTRANSFERASE; 1.
DR   PANTHER; PTHR16458:SF2; GLYCINE N-METHYLTRANSFERASE; 1.
DR   Pfam; PF13649; Methyltransf_25; 1.
DR   PIRSF; PIRSF000385; Gly_N-mtase; 1.
DR   SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1.
DR   PROSITE; PS51600; SAM_GNMT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   Folate-binding; Methyltransferase; Phosphoprotein; Reference proteome;
KW   S-adenosyl-L-methionine; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2822402"
FT   CHAIN           2..293
FT                   /note="Glycine N-methyltransferase"
FT                   /id="PRO_0000087528"
FT   BINDING         4
FT                   /ligand="(6S)-5-methyl-5,6,7,8-tetrahydrofolate"
FT                   /ligand_id="ChEBI:CHEBI:18608"
FT                   /ligand_label="1"
FT                   /ligand_note="ligand shared between tetrameric partners"
FT                   /evidence="ECO:0000269|PubMed:22037183,
FT                   ECO:0000312|PDB:3THR, ECO:0000312|PDB:3THS"
FT   BINDING         6
FT                   /ligand="(6S)-5-methyl-5,6,7,8-tetrahydrofolate"
FT                   /ligand_id="ChEBI:CHEBI:18608"
FT                   /ligand_label="1"
FT                   /ligand_note="ligand shared between tetrameric partners"
FT                   /evidence="ECO:0000269|PubMed:17158459,
FT                   ECO:0000312|PDB:2IDK"
FT   BINDING         6
FT                   /ligand="(6S)-5-methyl-5,6,7,8-tetrahydrofolate"
FT                   /ligand_id="ChEBI:CHEBI:18608"
FT                   /ligand_label="2"
FT                   /ligand_note="ligand shared between tetrameric partners"
FT                   /evidence="ECO:0000269|PubMed:22037183,
FT                   ECO:0000312|PDB:3THS"
FT   BINDING         22
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000269|PubMed:12859184,
FT                   ECO:0007744|PDB:1NBH"
FT   BINDING         31
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000269|PubMed:12859184,
FT                   ECO:0007744|PDB:1NBH, ECO:0007744|PDB:1NBI"
FT   BINDING         34
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000269|PubMed:8810903,
FT                   ECO:0007744|PDB:1XVA"
FT   BINDING         41
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000269|PubMed:12859184,
FT                   ECO:0007744|PDB:1NBH, ECO:0007744|PDB:1NBI"
FT   BINDING         65
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000269|PubMed:12859184,
FT                   ECO:0000269|PubMed:8810903, ECO:0000312|PDB:1XVA,
FT                   ECO:0007744|PDB:1NBH, ECO:0007744|PDB:1NBI"
FT   BINDING         86..88
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000269|PubMed:12859184,
FT                   ECO:0007744|PDB:1NBH, ECO:0007744|PDB:1NBI"
FT   BINDING         117..118
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000269|PubMed:12859184,
FT                   ECO:0007744|PDB:1NBH, ECO:0007744|PDB:1NBI"
FT   BINDING         137..140
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000269|PubMed:12859184,
FT                   ECO:0000269|PubMed:8810903, ECO:0007744|PDB:1NBI,
FT                   ECO:0007744|PDB:1XVA"
FT   BINDING         176
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000269|PubMed:8810903,
FT                   ECO:0007744|PDB:1XVA"
FT   BINDING         215
FT                   /ligand="(6S)-5-methyl-5,6,7,8-tetrahydrofolate"
FT                   /ligand_id="ChEBI:CHEBI:18608"
FT                   /ligand_label="2"
FT                   /ligand_note="ligand shared between tetrameric partners"
FT                   /evidence="ECO:0000269|PubMed:22037183,
FT                   ECO:0000312|PDB:3THR, ECO:0000312|PDB:3THS"
FT   BINDING         221
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000269|PubMed:8810903,
FT                   ECO:0007744|PDB:1XVA"
FT   BINDING         240
FT                   /ligand="(6S)-5-methyl-5,6,7,8-tetrahydrofolate"
FT                   /ligand_id="ChEBI:CHEBI:18608"
FT                   /ligand_label="1"
FT                   /ligand_note="ligand shared between tetrameric partners"
FT                   /evidence="ECO:0000269|PubMed:22037183,
FT                   ECO:0000312|PDB:3THR, ECO:0000312|PDB:3THS"
FT   BINDING         240
FT                   /ligand="(6S)-5-methyl-5,6,7,8-tetrahydrofolate"
FT                   /ligand_id="ChEBI:CHEBI:18608"
FT                   /ligand_label="2"
FT                   /ligand_note="ligand shared between tetrameric partners"
FT                   /evidence="ECO:0000269|PubMed:22037183,
FT                   ECO:0000312|PDB:3THR, ECO:0000312|PDB:3THS"
FT   MOD_RES         2
FT                   /note="N-acetylvaline"
FT                   /evidence="ECO:0000269|PubMed:2822402"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXF8"
FT   MOD_RES         34
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXF8"
FT   MOD_RES         46
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXF8"
FT   MOD_RES         191
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXF8"
FT   MOD_RES         196
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXF8"
FT   MOD_RES         201
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXF8"
FT   MUTAGEN         34
FT                   /note="Y->F: Reduces affinity for glycine."
FT                   /evidence="ECO:0000269|PubMed:12859184"
FT   MUTAGEN         176
FT                   /note="R->K: Strongly reduced affinity for glycine."
FT                   /evidence="ECO:0000269|PubMed:12859184"
FT   MUTAGEN         221
FT                   /note="Y->F: Reduces affinity for glycine."
FT                   /evidence="ECO:0000269|PubMed:12859184"
FT   STRAND          5..9
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          11..13
FT                   /evidence="ECO:0007829|PDB:1NBH"
FT   TURN            21..24
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   HELIX           26..35
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          39..41
FT                   /evidence="ECO:0007829|PDB:2IDJ"
FT   HELIX           43..55
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          60..63
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   HELIX           70..77
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          81..87
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   HELIX           89..101
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   TURN            102..104
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   HELIX           106..109
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          112..115
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   HELIX           118..120
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   HELIX           121..124
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          131..136
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   TURN            137..139
FT                   /evidence="ECO:0007829|PDB:1NBH"
FT   HELIX           141..143
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          147..151
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   HELIX           152..163
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          165..176
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   HELIX           178..184
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          193..195
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          202..210
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          213..225
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          229..232
FT                   /evidence="ECO:0007829|PDB:1XVA"
FT   STRAND          235..243
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   HELIX           248..257
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   TURN            258..261
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          263..269
FT                   /evidence="ECO:0007829|PDB:3THR"
FT   STRAND          283..291
FT                   /evidence="ECO:0007829|PDB:3THR"
SQ   SEQUENCE   293 AA;  32549 MW;  4E98C7512F0228A5 CRC64;
     MVDSVYRTRS LGVAAEGIPD QYADGEAARV WQLYIGDTRS RTAEYKAWLL GLLRQHGCHR
     VLDVACGTGV DSIMLVEEGF SVTSVDASDK MLKYALKERW NRRKEPAFDK WVIEEANWLT
     LDKDVPAGDG FDAVICLGNS FAHLPDSKGD QSEHRLALKN IASMVRPGGL LVIDHRNYDY
     ILSTGCAPPG KNIYYKSDLT KDITTSVLTV NNKAHMVTLD YTVQVPGAGR DGAPGFSKFR
     LSYYPHCLAS FTELVQEAFG GRCQHSVLGD FKPYRPGQAY VPCYFIHVLK KTG
//
